Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 21 Issue 2, February 2019

Cancer

The perivascular niche confers chemoresistance

See Carlson et al. and News & Views by Klein

Image: Cyrus Ghajar, Fred Hutchinson Cancer Research Center. Cover Design: Lauren Heslop.

Editorial

  • Science thrives on the free exchange of ideas and collaboration between diverse groups, with researcher mobility greatly accelerating progress. With isolationist rhetoric increasingly dominating the political discourse in many countries, it is important to recognize the value of migration in science.

    Editorial

    Advertisement

Top of page ⤴

News & Views

  • AKT, also known as protein kinase B, is one of the most frequently dysregulated serine/threonine kinases in cancer, and its hyperactivity drives tumorigenesis and chemotherapy resistance. Two studies now find that AKT methylation by the methyltransferase SETDB1 is an early step in its oncogenic activation.

    • Amelia K. Luciano
    • David A. Guertin
    News & Views
  • Stressed eukaryotic cells store mRNAs in protein-rich condensates called stress granules. Using single-molecule tracking techniques to examine how mRNAs enter stress granules, a new study shows that mRNAs make transient contacts with the granule surface before stable association, and become largely immobile after entry.

    • Chih-Yung Lee
    • Geraldine Seydoux
    News & Views
  • It is commonly accepted that disseminated tumour cells survive cytotoxic chemotherapy because they are not proliferating. A new study now finds that, in contrast to this long-standing concept, both dormant and proliferative cancer cells can be protected from chemotherapy when they reside at the perivascular niche.

    • Melanie Werner-Klein
    • Christoph A. Klein
    News & Views
  • Patients with diabetes could benefit from cell-based insulin therapy, but the supply of human islet tissue is limited. A study now reports an approach in which human-pluripotent-stem-cell-derived islet β-cells are purified and re-aggregated to generate cells that more closely resemble mature human β-cells.

    • Hans E. Hohmeier
    • Jie An
    • Christopher B. Newgard
    News & Views
Top of page ⤴

Review Articles

Top of page ⤴

Letters

Top of page ⤴

Articles

Top of page ⤴

Technical Reports

Top of page ⤴

Search

Quick links